Gavrila Alina, Chan Jean L, Miller Lisa C, Heist Kathleen, Yiannakouris Nikos, Mantzoros Christos S
Division of Endocrinology and Metabolism, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
J Clin Endocrinol Metab. 2005 Feb;90(2):1047-54. doi: 10.1210/jc.2004-1124. Epub 2004 Nov 16.
We evaluated whether circulating levels of melanin-concentrating hormone (MCH), agouti-related protein (AGRP), and alpha-MSH could serve as useful markers of energy homeostasis in humans. We first assessed correlations of serum MCH, AGRP, and alpha-MSH with anthropometric, dietary, and hormonal variables in a cross-sectional study of 108 healthy humans. We then performed interventional studies to evaluate the effects of fasting and/or leptin administration. In eight healthy, normal weight men, we measured serum MCH, AGRP, and alpha-MSH levels at baseline, after 2 d of fasting alone (a low leptin state), and after 2 d of fasting with replacement dose recombinant methionyl human leptin (r-metHuLeptin) administration to normalize circulating leptin levels. In a separate group of five lean and five obese men, we measured MCH levels in response to increasing circulating leptin levels to the pharmacological range by administration of one r-metHuLeptin dose in the fed state. In the cross-sectional study, serum MCH levels were independently and positively associated with body mass index and fat mass and were higher in women than in men. Furthermore, in our interventional studies, fasting for 2 d significantly decreased leptin levels and increased serum MCH levels. Administration of replacement dose r-metHuLeptin during fasting prevented the fasting-induced increase in MCH levels, but administration of a pharmacological r-metHuLeptin dose in the fed state did not further alter MCH levels. Serum AGRP levels tended to change in directions similar to MCH, but this change was less pronounced and needs to be investigated in larger studies. In contrast, serum alpha-MSH levels did not correlate with body composition parameters, were not associated with caloric or macronutrient intake, and were not significantly affected by fasting or r-metHuLeptin administration. These findings suggest that serum MCH and possibly AGRP levels could serve as useful peripheral markers of changes in energy homeostasis and thus merit additional investigation.
我们评估了黑色素浓缩激素(MCH)、刺鼠相关蛋白(AGRP)和α-促黑素(alpha-MSH)的循环水平是否可作为人类能量稳态的有用标志物。我们首先在一项针对108名健康人的横断面研究中,评估了血清MCH、AGRP和alpha-MSH与人体测量学、饮食和激素变量之间的相关性。然后,我们进行了干预性研究,以评估禁食和/或注射瘦素的效果。在8名健康、体重正常的男性中,我们在基线时、单独禁食2天(低瘦素状态)后以及禁食2天并注射替代剂量重组蛋氨酰人瘦素(r-metHuLeptin)以使循环瘦素水平正常化后,测量了血清MCH、AGRP和alpha-MSH水平。在另一组由5名瘦人和5名肥胖男性组成的群体中,我们通过在进食状态下注射一剂r-metHuLeptin,将循环瘦素水平提高到药理范围,测量了MCH水平的变化。在横断面研究中,血清MCH水平与体重指数和脂肪量独立且呈正相关,女性高于男性。此外,在我们的干预性研究中,禁食2天显著降低了瘦素水平并提高了血清MCH水平。禁食期间注射替代剂量的r-metHuLeptin可防止禁食诱导的MCH水平升高,但在进食状态下注射药理剂量的r-metHuLeptin并未进一步改变MCH水平。血清AGRP水平的变化趋势与MCH相似,但这种变化不太明显,需要在更大规模的研究中进行调查。相比之下,血清alpha-MSH水平与身体成分参数无关,与热量或常量营养素摄入无关,并且不受禁食或r-metHuLeptin注射的显著影响。这些发现表明,血清MCH水平以及可能的AGRP水平可作为能量稳态变化的有用外周标志物,因此值得进一步研究。